Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government what is their estimate of the number of nurses and midwives from other EU countries who have returned to their country of origin in the last two years.
Answered by Lord O'Shaughnessy
The information requested is not collected by the Department.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty's Government whether they anticipate a reduction in the number of nurses and midwives from EU countries coming to the UK after Brexit; if so, by how much; and what assessment they have made of the impact on the NHS of any such reduction.
Answered by Lord O'Shaughnessy
The Government hugely values the contribution of all the European Union staff working across the National Health Service and social care, including nurses and midwives. The Government is committed to ensuring a clear pathway to permanent residency for these EU citizens.
The Department continues to monitor and analyse overall staffing levels across the NHS and social care, and we are working across Government to ensure there will continue to be sufficient staff to deliver the high quality services on which patients rely following the United Kingdom’s exit from the EU.
We are also working hard to improve our domestic supply of nurses and midwives. This year there are more nurses on our wards than last year and numbers will continue to increase in future because of a 25% increase in training places, the introduction of new routes into the profession through the Nursing Degree Apprenticeship, and an increase in the number of nurse associates.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Home Office:
To ask Her Majesty's Government whether they plan to follow the United States and designate the Iranian Revolutionary Guard Corps as a terrorist organisation.
Answered by Baroness Williams of Trafford - Captain of the Honourable Corps of Gentlemen-at-Arms (HM Household) (Chief Whip, House of Lords)
Whilst we keep the list of proscribed groups under review, we do not routinely comment on whether an organisation is or is not under consideration for proscription.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department for Education:
To ask Her Majesty’s Government, in the light of reports of increasing anti-Semitism in the UK, whether they will consult university Vice-Chancellors about what action they can take on the decision of the National Union of Students (NUS) to prevent the Union of Jewish Students from recommending a representative on the NUS Anti-Racism, Anti-Fascist Task Force.
Answered by Earl of Courtown - Captain of the Queen's Bodyguard of the Yeomen of the Guard (HM Household) (Deputy Chief Whip, House of Lords)
There is no place in our society for bigotry, hatred or any form of racism such as anti-Semitism.
Higher Education Institutions are committed to challenging intolerance on campus. They have a clear responsibility under the 2010 Equality Act to provide a safe and inclusive environment.
Student clubs, societies and associations, with a membership of over 25, are covered by the applicable requirements of the Equality Act 2010. This means they cannot discriminate, harass or victimise protected groups, as an employer, or in the provision of goods services and facilities, or as members or guests.
We would expect all bodies representing students in English universities to be clear that there is no place for anti-Semitism in higher education. They should be doing everything they can to tackle anti-Semitism as they would all forms of racism.
In response to growing concerns over hate crime Universities UK have established a Harassment Taskforce to consider further measures to address harassment on campus including religion and belief. Government has asked the UUK Taskforce to consider a number of specific actions in relation to anti-Semitism:
The need for an improved data collection of incidents by institution, to ensure Universities are recording incidents effectively;
The importance of a complaints process that protects the identity of students who are fearful of coming forward;
The need for better training to help University staff understand the different forms anti-Semitism can take.
The taskforce will provide a range of recommendations and actions in its report to ministers in the autumn.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department for International Development:
To ask Her Majesty’s Government, further to the Written Answer by Baroness Verma on 7 July 2016 (HL799), what discussion they have had with the Palestinian Authority about its non-attendance at meetings with Israeli officials on the Joint Water Committee.
Answered by Baroness Anelay of St Johns
Continuity of water supply to the West Bank is essential for both the basic needs of Palestinians and for stability and security more widely. The UK regularly raises the issue of water in the Occupied Palestinian Territories with the Palestinian Authority and Government of Israel. We encourage both parties to find a swift resolution to this issue and to reconvene the Joint Water Committee.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government, following the removal of the role of the National Clinical Director for gastrointestinal and liver diseases, what other forms of information and advice on those diseases are available to NHS England.
Answered by Lord Prior of Brampton
In future, NHS England will seek clinical advice on issues relating to gastrointestinal and liver disease from a variety of sources. This will include experts at Public Health England (PHE) for issues which are alcohol related, the National Clinical Director for Obesity and Diabetes for issues relating to obesity induced fatty liver disease as well as through the Clinical Reference Group for hepatitis C and the medical Royal Colleges.
Information on liver and gastrointestinal (GI) diseases is also available from the National Institute for Health and Care Excellence, PHE Atlases of variation, relevant national audits and regular clinical communication between the national Medical Director, his senior team and the relevant Royal Colleges and specialist societies and with senior professionals.
NHS England continues to run an Endoscopy Stakeholder Group to ensure that all aspects of diagnostic pathways for GI disease are reviewed and clinical advice is taken regarding policy developments to address the current and projected requirement in capacity. The relevant specialist societies are key members of this group. NHS England also supports the national Cancer Implementation Programme on behalf of the arm’s length bodies, which includes workstreams on early diagnosis, and on living with and beyond cancer, both of which are addressing many issues that affect patients with GI cancers.
Health Education England will continue to ensure that they engage with employers to forecast how many gastroenterologists they require year on year. The process for making decisions relating to medical training numbers is currently being refined. Medical speciality training post numbers will be reviewed in greater depth with a range of stakeholders on a rolling programme; approximately every two years. Gastroenterology is expected to be reviewed this winter.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government whether NHS England will seek advice from specialist gastrointestinal disease societies following the removal of the role of National Clinical Director for that area.
Answered by Lord Prior of Brampton
In future, NHS England will seek clinical advice on issues relating to gastrointestinal and liver disease from a variety of sources. This will include experts at Public Health England (PHE) for issues which are alcohol related, the National Clinical Director for Obesity and Diabetes for issues relating to obesity induced fatty liver disease as well as through the Clinical Reference Group for hepatitis C and the medical Royal Colleges.
Information on liver and gastrointestinal (GI) diseases is also available from the National Institute for Health and Care Excellence, PHE Atlases of variation, relevant national audits and regular clinical communication between the national Medical Director, his senior team and the relevant Royal Colleges and specialist societies and with senior professionals.
NHS England continues to run an Endoscopy Stakeholder Group to ensure that all aspects of diagnostic pathways for GI disease are reviewed and clinical advice is taken regarding policy developments to address the current and projected requirement in capacity. The relevant specialist societies are key members of this group. NHS England also supports the national Cancer Implementation Programme on behalf of the arm’s length bodies, which includes workstreams on early diagnosis, and on living with and beyond cancer, both of which are addressing many issues that affect patients with GI cancers.
Health Education England will continue to ensure that they engage with employers to forecast how many gastroenterologists they require year on year. The process for making decisions relating to medical training numbers is currently being refined. Medical speciality training post numbers will be reviewed in greater depth with a range of stakeholders on a rolling programme; approximately every two years. Gastroenterology is expected to be reviewed this winter.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government what mechanisms they plan to employ to seek advice on workforce planning for gastroenterology following the removal of the role of National Clinical Director for that area.
Answered by Lord Prior of Brampton
In future, NHS England will seek clinical advice on issues relating to gastrointestinal and liver disease from a variety of sources. This will include experts at Public Health England (PHE) for issues which are alcohol related, the National Clinical Director for Obesity and Diabetes for issues relating to obesity induced fatty liver disease as well as through the Clinical Reference Group for hepatitis C and the medical Royal Colleges.
Information on liver and gastrointestinal (GI) diseases is also available from the National Institute for Health and Care Excellence, PHE Atlases of variation, relevant national audits and regular clinical communication between the national Medical Director, his senior team and the relevant Royal Colleges and specialist societies and with senior professionals.
NHS England continues to run an Endoscopy Stakeholder Group to ensure that all aspects of diagnostic pathways for GI disease are reviewed and clinical advice is taken regarding policy developments to address the current and projected requirement in capacity. The relevant specialist societies are key members of this group. NHS England also supports the national Cancer Implementation Programme on behalf of the arm’s length bodies, which includes workstreams on early diagnosis, and on living with and beyond cancer, both of which are addressing many issues that affect patients with GI cancers.
Health Education England will continue to ensure that they engage with employers to forecast how many gastroenterologists they require year on year. The process for making decisions relating to medical training numbers is currently being refined. Medical speciality training post numbers will be reviewed in greater depth with a range of stakeholders on a rolling programme; approximately every two years. Gastroenterology is expected to be reviewed this winter.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government whether they have assessed the plans of NHS England for provision of mandated research in the NHS.
Answered by Lord Prior of Brampton
The Department of Health formally holds NHS England to account on its delivery against the research objective in the NHS Mandate, a process which will be rolled forward during 2016/7.
Progress has been made in the areas of participation of National Health Service organisations in research, with 98% of NHS trusts recruited into National Institute for Health Research Clinical Research Network Portfolio studies during the course of 2014/15, and 78% of NHS trusts recruiting to commercial contract studies in the same year. In addition, recruitment of participants into such studies increased in 2014/15 compared to the previous year to 618,453 participants. Recruitment into commercial contract studies is at an all-time high, with 34,885 participants in 2014/15; a 35% increase from 2013/14.
Asked by: Lord Turnberg (Labour - Life peer)
Question to the HM Treasury:
To ask Her Majesty’s Government, further to the Written Answer by Lord O’Neill of Gatley on 17 February (HL5889), whether they intend to collect data on the payments made to EU immigrants for their children living in their home countries.
Answered by Lord O'Neill of Gatley
Around 7m people are receiving Child Benefit. To extract and collate the value of all payments made to EU migrants for children living outside the UK in the format requested could only be provided at disproportionate cost.
Information relating to the number of Child Benefit claims paid to families with children living overseas is available in the Government publication , “The best of both worlds: the United Kingdom's special status in a reformed European Union”. This publication is available on Gov.uk